Bo Lumholtz

482 total citations
11 papers, 364 citations indexed

About

Bo Lumholtz is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Bo Lumholtz has authored 11 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Pharmacology. Recurrent topics in Bo Lumholtz's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Pharmaceutical studies and practices (3 papers). Bo Lumholtz is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Pharmaceutical studies and practices (3 papers). Bo Lumholtz collaborates with scholars based in Denmark, Sweden and United Kingdom. Bo Lumholtz's co-authors include Jens Hansen, Jens P. Kampmann, Staffan Eksborg, Michael G. Hall, Martin F. Wilks, Kaj Siersbæk‐Nielsen, W. McLean Provan, P. Platz, Jørgen Hannover Larsen and Mogens Thomsen and has published in prestigious journals such as American Journal of Psychiatry, Clinical Pharmacology & Therapeutics and Clinical Pharmacokinetics.

In The Last Decade

Bo Lumholtz

11 papers receiving 333 citations

Peers

Countries citing papers authored by Bo Lumholtz

Since Specialization

Citations

This map shows the geographic impact of Bo Lumholtz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Lumholtz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Lumholtz more than expected).

Fields of papers citing papers by Bo Lumholtz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Lumholtz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Lumholtz. The network helps show where Bo Lumholtz may publish in the future.

Co-authorship network of co-authors of Bo Lumholtz

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Lumholtz. A scholar is included among the top collaborators of Bo Lumholtz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Lumholtz. Bo Lumholtz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Pharmacokinetics and pharmacodynamics of NTBC (2‐(2‐nitro‐4‐fluoromethylbenzoyl)‐1,3‐cyclohexanedione) and mesotrione, inhibitors of 4‐hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers 2001 ·British Journal of Clinical Pharmacology ·Michael G. Hall, Martin F. Wilks, W. McLean Provan, Staffan Eksborg, Bo Lumholtz	76
2	Effect of amitriptyline on the thyrotropin response to thyrotropin-releasing hormone in endogenous depression 1985 ·Psychiatry Research ·(unknown), C. Kirkegaard, (unknown), Bo Lumholtz, (unknown), (unknown), N. Bjørum	14
3	Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression 1984 ·American Journal of Psychiatry ·(unknown), C. Kirkegaard, (unknown), Bo Lumholtz, (unknown), (unknown), N. Bjørum	38
4	Ampicillin and Propylthiouracil Pharmacokinetics in Intestinal Bypass Patients Followed Up to a Year after Operation 1984 ·Clinical Pharmacokinetics ·Jens P. Kampmann, (unknown), Bo Lumholtz, (unknown)	22
5	Unaltered Metabolism of Phenytoin in Thyroid Disorders 1978 ·Acta Pharmacologica et Toxicologica ·Jens M. Hansen, L. Skovsted, Jens P. Kampmann, Bo Lumholtz, Kaj Siersbæk‐Nielsen	15
6	EXTRATHYROIDAL EFFECTS OF PROPYLTHIOURACIL AND CARBIMAZOLE ON SERUM T4, T3, REVERSE T3 AND TRH-INDUCED TSH-RELEASE IN MAN 1978 ·European Journal of Endocrinology ·K. Siersbæk‐Nielsen, C. Kirkegaard, (unknown), Jens Faber, Bo Lumholtz, Th. Friis	6
7	HLA ANTIGENS IN GRAVES' DISEASE 1977 ·European Journal of Endocrinology ·Karine Bech, Bo Lumholtz, Jørn Nerup, Mogens Thomsen, P. Platz, Lars P. Ryder, Arne Svejgaard, Kaj Siersbæk‐Nielsen, Jens Hansen, Jørgen Hannover Larsen	119
8	Sulfamethizole‐induced inhibition of diphenylhydantoin, tolbutamide, and warfarin metabolism 1975 ·Clinical Pharmacology & Therapeutics ·Bo Lumholtz, (unknown), L. Skovsted, Jens P. Kampmann, Jens Hansen	40
9	DRUG ELIMINATION AND RENAL FUNCTION 1974 ·The Journal of Clinical Pharmacology ·M. Kristensen, J. Mølholm Hansen, J. P. Kampmann, Bo Lumholtz, K. Siersbæk‐Nielsen, Donald Perrier, Milo Gibaldi	19
10	[Dosage regime for kanamycin, gentamicin and digoxin. Presentation of a slide-rule for the calculation of creatinine clearance and doses of drugs]. 1974 ·PubMed ·J. P. Kampmann, Mie Kristensen, K. Siersbæk‐Nielsen, (unknown), Bo Lumholtz, (unknown), Jakob Møller Hansen	2
11	DOSE REGIMEN OF KANAMYCIN AND GENTAMICIN 1974 ·Acta Medica Scandinavica ·Bo Lumholtz, J. P. Kampmann, (unknown), Jens Hansen	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact